4
612
P. Ferraboschi et al. / Tetrahedron Letters 49 (2008) 4610–4612
Then, starting from 17
a
,21-dipropionate 7b,12 precursor of the
Acknowledgements
monoester endowed with the highest topical antiandrogenic activ-
1
ity, we screened several commercially available lipases under
This work was partially financially supported by Università
degli Studi di Milano. We thank Professor Fiamma Ronchetti for
helpful discussions.
alcoholysis conditions in organic solvents; these experimental con-
ditions were jugded more suitable, than the aqueous ones, to be
used for lipophilic substrates as steroids. Lipases from Pseudomo-
nas fluorescens (PFL) and from porcine pancreas (PPL) afforded neg-
ative results: PFL was able to transform only a little amount (10%)
of starting material 7b while no formation of monoester 3b was
observed, using PPL. Lipase from Candida antarctica B (CAL B)
showed to selectively remove the 21-acyl group, 77 and 91% con-
References and notes
1.
2.
3.
4.
Celasco, G.; Moro, L.; Bozzella, R.; Ferraboschi, P.; Bartorelli, L.; Quattrocchi, C.;
Nicoletti, F. Arzneim.-Forsch. 2004, 54, 881–886.
Celasco, G.; Moro, L.; Bozzella, R.; Ferraboschi, P.; Bartorelli, L.; Di Marco, R.;
Quattrocchi, C.; Nicoletti, F. Arzneim.-Forsch. 2005, 55, 581–587.
(a) Gardi, R.; Vitali, R.; Ercoli, A. Gazz. Chim. Ital. 1963, 93, 434–450; (b) Ercoli,
A.; Gardi, R. U.S. Patent 3,152,154, 1964.
version to 17
trile, respectively (see Table 1). Best results were observed when
,21-diester 7b was treated with lipase from Candida cylandra-
a-monoester 3b being achieved in toluene or acetoni-
Gardi, R.; Vitali, R.; Ercoli, A. Gazz. Chim. Ital. 1963, 93, 413–430.
1
7
a
5. Anderson, B. D.; Conradi, R. A.; Lambert, W. J. J. Pharm. Sci. 1984, 73, 604–611.
6. Carrea, G.; Riva, S. Angew. Chem., Int. Ed. 2000, 30, 2226–2254.
cea (CCL), with conversions depending on the chosen alcohol and
the solvent: in fact, using butanol or octanol as the acyl acceptor
and toluene as the solvent, a complete conversion was observed
after 24 h, and pure 17
90% yields (Scheme 1). The CCL-catalyzed alcoholysis is less effi-
7.
8.
9.
Gotor-Fernández, V.; Brieva, R.; Gotor, V. J. Mol. Catal. B: Enzym. 2006, 40, 111–
20.
Riva, S. In Applied Biocatalysis; Blanch, H. W., Clark, D. J., Eds.; M. Dekker: New
York, 1991; Vol. 1, pp 179–220.
Ferrero, M.; Gotor, V. In Stereoselective Biocatalysis; Patel, R. N., Ed.; M. Dekker:
New York, 2000; pp 579–631.
1
1
7
18
a-propionate 3b was recovered in
>
cient if methanol or ethanol are used as acyl acceptors or if more
polar solvents are chosen. The results are summarized in Table 1.
1
0. Turner, R. B. J. Am. Chem. Soc. 1953, 75, 3489–3492.
11. Cortexolone, 17
,21-diacetate 7a: 1H NMR (500 MHz, CDCl
5.71 (br s, 1H, H-4), 4.86 (d, 1H, H-21, J 16.5 Hz), 4.61 (d, 1H, H-21, J 16.5 Hz),
a
3
): selected data d
,21-diacetate 7a,11 dibutyrate 7c and divalerate 7d
13
14
Also 17a
2
1
.14 (s, 3H, CH
8CH ).
3
CO), 2.08 (s, 3H, CH ), 0.73 (s, 3H,
,21-dipropionate 7b: 1H NMR (500 MHz, CDCl
): selected data d
3
3
CO), 1.17 (s, 3H, 19CH
3
were submitted to CCL-catalyzed alcoholysis in order to prepare
the other biologically active monoesters. Selective hydrolysis of
1-ester was confirmed, 17a
obtained as unique products (Scheme 1); no relevant differences in
the alcoholysis procedure were observed: only, the use of butanol
showed a slower conversion rate of dibutyrate 7c and divalerate
d. The results are collected in Table 2.
Finally, we prepared
derivative endowed with a high systemic antiandrogenic activity.
Also in this case the CCL-catalyzed transformation of diester 8 was
performed in toluene with different alcohols, comparing the con-
version rate at the same time. Best results, like for dipropionate
3
12. Cortexolone, 17
5.77 (br s, 1H, H-4), 4.93 (d, 1H, H-21, J 16.6 Hz), 4.65 (d, 1H, H-21, J 16.6 Hz),
.22 (s, 3H, 19CH ), 1.16–1.22 (t + t, 6H, CH ), 0.79 (s, 3H, 18CH ).
3. Cortexolone, 17 ,21-dibutyrate 7c: H NMR (500 MHz, CDCl ): selected data d
5.77 (br s, 1H, H-4), 4.92 (d, 1H, H-21, J 16.6 Hz), 4.64 (d, 1H, H-21, J 16.6 Hz),
.21 (s, 3H, 19CH ), 0.97–1.04 (t + t, 6H, CH ), 0.78 (s, 3H, 18CH ).
4. Cortexolone, 17 ,21-divalerate 7d: H NMR (500 MHz, CDCl ): selected data d
.77 (br s, 1H, H-4), 4.92 (d, 1H, H-21, J 16.5 Hz), 4.63 (d, 1H, H-21, J 16.5 Hz),
a
-monoesters 3a,19 3c and 3d being
20
21
2
1
3
3
3
1
1
a
3
1
3
3
3
1
1
a
3
7
5
9
D
-cortexolone 17
a
-butyrate 4, that is, the
1.22 (s, 3H, 19CH ), 0.92-0.97 (t + t, 6H, CH ), 0.79 (s, 3H, 18CH ).
3
3
3
2
9
,21-dibutyrate 8: 1H NMR (500 MHz, CDCl
15.
D
-Cortexolone, 17
a
3
): selected data d
5
1
1
.78 (br s, 1H, H-4), 5.59 (m, 1H, H-11), 4.94 (d, 1H, H-21, J 16.6 Hz), 4.66 (d,
H, H-21, J 16.6 Hz), 1.36 (s, 3H, 19CH ), 0.96–1.03 (t + t, 6H, CH ), 0.74 (s, 3H,
8CH ).
is commercially available (Aldrich); its D9-derivative was
3
3
3
16. Cortexolone
1
prepared according a reported procedure starting from cortisol: Chamberlin,
E. M.; Tristram, E. W.; Utne, T.; Chemerda, J. M. J. Org. Chem. 1960, 25, 295.
7. Typical procedure of CCL-catalyzed alcoholysis: To a solution of cortexolone,
7
b, were observed using butanol or octanol as acyl acceptors, a
complete conversion of diester 8 to monoester 4 being achieved
22
1
after 53 h (Table 3, Scheme 1).
17
a,21-dipropionate 7b (0.5 g, 1.09 mmol) in toluene (35 mL), n-butanol (0.4 g,
5.45 mmol) and CCL (23 g, 3.86 U/mg, FLUKA) were added. The mixture was
kept at 30 °C under stirring, monitoring the reaction progress by TLC
3
. Conclusion
(PhCH /AcOEt) until starting material disappearance (24 h). The enzyme was
3
removed by filtration on a Celite pad. After evaporation of solvent at reduced
pressure pure cortexolone, 17a-propionate 3b was recovered (0.420 g, 96%).
Crystallization from isopropylether afforded 3b with the required purity for
The CCL-catalyzed alcoholysis in organic solvents, selectively
removing the 21-acyl group, allowed us to prepare 17
a-mono-
biological test (>99% by HPLC).
3
a ): selected data d 5.78
-propionate 3b: 1H NMR (500 MHz, CDCl
esters 3a–d and 4 in good yields and with the required purity
>99%), avoiding the 17?21 acyl migration.
Additionally, it is important to underline that CCL can be recy-
cled at least four times, without sensible decrease of enzymatic
activity: in fact the recovered enzyme from alcoholysis of 7b to
b was reused, under the same reaction conditions (toluene as
the solvent, butanol as the acyl acceptor and 24 h as the reaction
time), and, after the fourth cycle, we observed only a lowered con-
version from 100% to 94%.
Moreover, this chemoenzymatic approach represents a simple
preparative method that could be used, after the suitable develop-
18. Cortexolone, 17
br s, 1H, H-4), 4.32 (dd, 1H, H-21, J 18.3 and 4.9 Hz), 4.25 (dd, 1H, H-21, J 18.3
and 4.9 Hz), 1.22 (s, 3H, CH -19), 1.17 (t, 3H, CH , J 7.6 Hz), 0.72 (s, 3H, CH -18).
Mp 133 °C (t-butylmethylether).
19. Cortexolone, 17
-acetate 3a: 1H NMR (500 MHz, CDCl
s, 1H, H-4), 4.20–4.35 (d + d, 2H, H-21), 2.10 (s, 3H, CH
9), 0.70 (s, 3H, CH -18). Mp 195 °C (acetone/diethylether).
0. Cortexolone, 17 -butyrate 3c: H NMR (500 MHz, CDCl
(br s, 1H, H-4), 4.32 (dd, 1H, H-21, J 18.0 and 4.5 Hz), 4.26 (dd, 1H, H-21, J 18.0
and 4.5 Hz), 1.22 (s, 3H, CH -19), 0.99 (t, 3H, CH , J 7.5 Hz), 0.71 (s, 3H, CH -18).
Mp 135 °C (isopropylether).
(
(
3
3
3
a
3
): selected data d 5.76 (br
CO), 1.21 (s, 3H, CH
3
3
-
1
3
3
1
2
2
2
a
3
): selected data d 5.78
3
3
3
-valerate 3d: 1H NMR (500 MHz, CDCl
1. Cortexolone, 17
(br s, 1H, H-4), 4.31 (dd, 1H, H-21, J 18.1 and 4.5 Hz), 4.26 (dd, 1H, H-21, J 18.1
and 4.5 Hz), 1.21 (s, 3H, CH -19), 0.94 (t, 3H, CH , J 7.2 Hz), 0.72 (s, 3H, CH -18).
Mp 114 °C (isopropylether).
a
3
): selected data d 5.77
3
3
3
ment, for a future scaling up (i.e., in a continuous packed-bed
9
-butyrate 4: 1H NMR (500 MHz, CDCl
(br s, 1H, H-4), 5.57 (m, 1H, H-11), 4.29 (dd, 1H, H-21, J 18.0 and 4.5 Hz), 4.24
(dd, 1H, H-21, J 18.0 and 4.5 Hz), 1.37 (s, 3H, CH -19), 0.98 (t, 3H, CH , J 7.5 Hz),
.66 (s, 3H, CH -18). Mp 136 °C (acetone/hexane).
2.
D
-Cortexolone, 17
a
3
): selected data d 5.77
9
reactor) of the synthesis of cortexolone and
D
-cortexolone 17
a
-
monoesters, recently recognized as antiandrogenic compounds,
in good yields and purity.
3
3
0
3